A Clinical Study to Determine the Safety and Efficacy of an Oral Probiotic Supplementation to Improve Bacterial Vaginosis in Females

Inclusion Criteria

• •1. The subject is a healthy non-pregnant/non-lactating females aged 18 to 55 years.
• •2. Subjects having refrigerator at their home for storage of test treatment.
• •3. Presence of bacterial vaginosis (BV) as determined by gynaecological examination, including assessment for clinical symptoms such as abnormal vaginal discharge, malodour (moderate to very intense), and other relevant clinical indicators.
• •4. The subject is willing to provide written informed consent and follow study procedures.
• •5. The subject is willing to abide by the study protocol and restrictions, including abstaining from using any other intimate wash, lubricant, or treats during the study.
• •6. The subject is willing to use a highly effective method of contraception throughout the clinical investigation. This includes:
• •1. Females of childbearing potential must practice and maintain an established method of birth control (e.g., IUD, diaphragm, condoms with spermicide, partner vasectomy, or abstinence).
• •2. Non-childbearing potential females who are surgically sterile, post-menopausal for at least 1 year, or have had a tubal ligation, and agree to continue using the same contraception for the study duration.
• •7. Agreement for gynaecological pelvic examination by a Gynaecologist.
• •8. The subject is willing to abstain from sexual intercourse for a period of 24 hours before scheduled study visits to minimize potential interference with study assessments and measurements.